Hematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationHematopoietic Stem CellsGraft vs Host DiseaseStem Cell TransplantationBone MarrowTransplantation ConditioningTransplantation, AutologousBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraPeripheral Blood Stem Cell TransplantationStem CellsWhole-Body IrradiationTissue DonorsLeukemiaGraft SurvivalBusulfanHistocompatibility TestingHematopoiesisHistocompatibilityTreatment OutcomeGraft vs Leukemia EffectRecurrenceGraft vs Tumor EffectAnemia, AplasticAntigens, CD34Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCord Blood Stem Cell TransplantationRemission InductionHematopoietic Stem Cell MobilizationRetrospective StudiesBone and BonesMyeloablative AgonistsMice, Inbred C57BLImmunosuppressive AgentsChimerismCell DifferentiationMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseTime FactorsCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesLymphocyte TransfusionLymphocyte DepletionTransplantation, IsogeneicHLA AntigensMultiple MyelomaCyclophosphamideT-LymphocytesFlow CytometryTransplantation ImmunologyRadiation ChimeraLiver TransplantationAcute DiseaseSurvival AnalysisSurvival RateCell LineageColony-Forming Units AssayCytomegalovirus InfectionsMesenchymal Stem Cell TransplantationDisease-Free SurvivalSevere Combined ImmunodeficiencyImmunosuppressionGranulocyte Colony-Stimulating FactorLeukocyte TransfusionLeukemia, MyeloidGraft RejectionVidarabineCell TransplantationCells, CulturedSiblingsUnrelated DonorsBone Marrow DiseasesStem Cell NicheSalvage TherapyCell SeparationMelphalanFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsAntilymphocyte SerumAdult Stem CellsEmbryonic Stem CellsBone Marrow PurgingLymphoma, Non-HodgkinFetal BloodGraft vs Host ReactionCyclosporineFatal OutcomeKidney TransplantationImmunocompromised HostCytarabineChimeraLymphoproliferative DisordersMesenchymal Stromal CellsMice, Inbred BALB CNeoplasm, Residual